Published in Appl Environ Microbiol on June 01, 1994
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol (2004) 3.53
Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2007) 2.56
Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol (2003) 2.50
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol (1995) 2.43
Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol (2000) 2.41
Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol (2003) 2.41
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev (2002) 2.20
Gene islands integrated into tRNA(Gly) genes confer genome diversity on a Pseudomonas aeruginosa clone. J Bacteriol (2002) 2.14
Sequence analysis of the mobile genome island pKLC102 of Pseudomonas aeruginosa C. J Bacteriol (2004) 2.04
Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol (2000) 1.98
Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biol (2006) 1.97
Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol (1996) 1.93
Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol (1996) 1.89
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun (2007) 1.81
Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis. J Clin Microbiol (2004) 1.80
A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota. PLoS Genet (2015) 1.77
Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol (2003) 1.70
Pseudomonas aeruginosa population structure revisited. PLoS One (2009) 1.68
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J Clin Microbiol (2005) 1.55
Four genotyping schemes for phylogenetic analysis of Pseudomonas aeruginosa: comparison of their congruence with multi-locus sequence typing. PLoS One (2013) 1.52
Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol (1995) 1.46
Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model. PLoS Pathog (2012) 1.38
A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother (2000) 1.33
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol (2000) 1.32
Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun (2004) 1.27
Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci U S A (2000) 1.26
The Pseudomonas aeruginosa rhlG gene encodes an NADPH-dependent beta-ketoacyl reductase which is specifically involved in rhamnolipid synthesis. J Bacteriol (1998) 1.25
Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol (2004) 1.25
Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol (2004) 1.24
Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations. Eur J Clin Microbiol Infect Dis (2009) 1.23
Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb Ecol (2007) 1.23
Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol (2010) 1.21
Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol (2012) 1.20
Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One (2012) 1.17
Multilocus sequence typing and phylogenetic analyses of Pseudomonas aeruginosa Isolates from the ocean. Appl Environ Microbiol (2008) 1.14
Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.12
Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet (2014) 1.12
Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections. PLoS One (2010) 1.11
Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun (2001) 1.11
The AHL- and BDSF-dependent quorum sensing systems control specific and overlapping sets of genes in Burkholderia cenocepacia H111. PLoS One (2012) 1.10
Strain-dependent diversity in the Pseudomonas aeruginosa quorum-sensing regulon. Proc Natl Acad Sci U S A (2012) 1.09
Comparison of flagellin genes from clinical and environmental Pseudomonas aeruginosa isolates. Appl Environ Microbiol (1999) 1.07
Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol (1996) 1.06
The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS One (2013) 1.00
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression. Antimicrob Agents Chemother (2010) 0.97
Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS One (2012) 0.97
Evaluation of a microarray-hybridization based method applicable for discovery of single nucleotide polymorphisms (SNPs) in the Pseudomonas aeruginosa genome. BMC Genomics (2009) 0.95
Investigation of persistent colonization by Pseudomonas aeruginosa-like strains in a spring water bottling plant. Appl Environ Microbiol (1997) 0.93
Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections. Infect Immun (2011) 0.92
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. J Clin Microbiol (2014) 0.90
Low occurrence of Pseudomonas aeruginosa in agricultural soils with and without organic amendment. Front Cell Infect Microbiol (2014) 0.88
Homeostasis and catabolism of choline and glycine betaine: lessons from Pseudomonas aeruginosa. Appl Environ Microbiol (2013) 0.87
Comparison of the worldwide transmissible Pseudomonas aeruginosa with isolates from brazilian cystic fibrosis patients. Braz J Microbiol (2010) 0.85
Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli. J Clin Microbiol (2004) 0.84
Cystic fibrosis presenting with corneal perforation and crystalline lens extrusion. J R Soc Med (2010) 0.83
A novel Pseudomonas aeruginosa bacteriophage, Ab31, a chimera formed from temperate phage PAJU2 and P. putida lytic phage AF: characteristics and mechanism of bacterial resistance. PLoS One (2014) 0.82
Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand. Ann Clin Microbiol Antimicrob (2012) 0.80
Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria. Curr Microbiol (2016) 0.78
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob Agents Chemother (2012) 0.78
A network biology approach to denitrification in Pseudomonas aeruginosa. PLoS One (2015) 0.77
A comparative study of coastal and clinical isolates of Pseudomonas aeruginosa. Braz J Microbiol (2015) 0.76
Intraclonal genome diversity of the major Pseudomonas aeruginosa clones C and PA14. Environ Microbiol Rep (2016) 0.76
Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables. Int J Microbiol (2012) 0.76
Antimicrobial resistance and genomic rep-PCR fingerprints of Pseudomonas aeruginosa strains from animals on the background of the global population structure. BMC Vet Res (2017) 0.75
Multidrug resistant Pseudomonas aeruginosa survey in a stream receiving effluents from ineffective wastewater hospital plants. BMC Microbiol (2016) 0.75
Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico City. Front Microbiol (2017) 0.75
Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers. mSphere (2016) 0.75
Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs. Genome Res (2017) 0.75
Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. BMC Microbiol (2016) 0.75
Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. Biotechnol Biotechnol Equip (2014) 0.75
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Organization of the bacterial chromosome. Microbiol Rev (1990) 6.01
Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol (1988) 4.27
Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis (1985) 3.61
A model for the separation of large DNA molecules by crossed field gel electrophoresis. Nucleic Acids Res (1987) 3.58
A physical genome map of Pseudomonas aeruginosa PAO. EMBO J (1989) 2.60
Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol (1984) 2.15
New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol (1991) 1.98
Pulsed-field gel electrophoresis applied for comparing Listeria monocytogenes strains involved in outbreaks. Can J Microbiol (1993) 1.96
Epidemiological typing of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (1988) 1.89
The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol (1986) 1.67
The absence of correlation between allozyme and rrn RFLP analysis indicates a high gene flow rate within human clinical Pseudomonas aeruginosa isolates. FEMS Microbiol Lett (1993) 1.32
Distribution of Pseudomonas aeruginosa in a riverine ecosystem. Appl Environ Microbiol (1983) 1.28
Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol (1993) 1.26
Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. Eur J Med (1993) 1.16
Localization of alg, opr, phn, pho, 4.5S RNA, 6S RNA, tox, trp, and xcp genes, rrn operons, and the chromosomal origin on the physical genome map of Pseudomonas aeruginosa PAO. J Bacteriol (1992) 1.13
Pulsed-field gel electrophoresis analysis of a Pseudomonas aeruginosa pathovar. Electrophoresis (1993) 1.08
Optimization of non-radioactive Southern blot hybridization: single copy detection and reuse of blots. Nucleic Acids Res (1990) 0.99
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11
Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol (1988) 4.27
Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res (1993) 3.26
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog (1990) 3.18
Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol (2001) 2.96
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
Cyclin D1 protein expression and function in human breast cancer. Int J Cancer (1994) 2.81
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66
Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis (1994) 2.64
A physical genome map of Pseudomonas aeruginosa PAO. EMBO J (1989) 2.60
Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol (1984) 2.51
Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol (2000) 2.41
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
The Tim core complex defines the number of mitochondrial translocation contact sites and can hold arrested preproteins in the absence of matrix Hsp70-Tim44. EMBO J (1997) 2.28
Mitochondrial protein import: biochemical and genetic evidence for interaction of matrix hsp70 and the inner membrane protein MIM44. J Cell Biol (1994) 2.28
Lysosomal (vacuolar) proteinases of yeast are essential catalysts for protein degradation, differentiation, and cell survival. J Biol Chem (1989) 2.25
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis (1999) 2.18
E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene (1998) 2.12
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol (1994) 2.11
Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution. J Bacteriol (2000) 1.98
New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol (1991) 1.98
In vivo biosynthesis of the vacuolar proteinases A and B in the yeast Saccharomyces cerevisiae. J Biol Chem (1982) 1.98
DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J Clin Invest (1999) 1.97
Sec8p and Sec15p are components of a plasma membrane-associated 19.5S particle that may function downstream of Sec4p to control exocytosis. J Cell Biol (1992) 1.96
Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol (1996) 1.93
Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats. J Mol Biol (1997) 1.93
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol (1980) 1.90
Sec2 protein contains a coiled-coil domain essential for vesicular transport and a dispensable carboxy terminal domain. J Cell Biol (1990) 1.86
Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother (1986) 1.83
Antibodies to high molecular weight polypeptides of desmosomes: specific localization of a class of junctional proteins in cells and tissue. Differentiation (1981) 1.77
Maturation of vacuolar (lysosomal) enzymes in yeast: proteinase yscA and proteinase yscB are catalysts of the processing and activation event of carboxypeptidase yscY. EMBO J (1987) 1.76
Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol (2001) 1.73
A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol (1995) 1.73
Preprotein translocase of the outer mitochondrial membrane: molecular dissection and assembly of the general import pore complex. Mol Cell Biol (1998) 1.71
Genomic mapping of Pseudomonas aeruginosa PAO. Microbiology (1994) 1.69
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res (1995) 1.68
Physical and genetic map of the Neisseria gonorrhoeae strain MS11-N198 chromosome. Mol Microbiol (1991) 1.67
DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Thorax (1995) 1.67
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol (2010) 1.67
Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest (2001) 1.63
Relevance of microbial extracellular polymeric substances (EPSs)--Part I: Structural and ecological aspects. Water Sci Technol (2001) 1.58
Genetic diversity of flagellins of Pseudomonas aeruginosa. FEBS Lett (1996) 1.57
Physical genome analysis of bacteria. Electrophoresis (1993) 1.56
Juvenile ossifying fibroma. Report of four cases. J Craniomaxillofac Surg (1990) 1.56
Metagenome survey of biofilms in drinking-water networks. Appl Environ Microbiol (2003) 1.54
Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol (2001) 1.54
Protein import channel of the outer mitochondrial membrane: a highly stable Tom40-Tom22 core structure differentially interacts with preproteins, small tom proteins, and import receptors. Mol Cell Biol (2001) 1.53
Functional staging of ADP/ATP carrier translocation across the outer mitochondrial membrane. J Biol Chem (1999) 1.52
Effects of early postfiltration ocular hypotony on visual acuity, long-term intraocular pressure control, and posterior segment morphology. J Glaucoma (2001) 1.51
Breast reconstruction with latissimus dorsi flap: improved aesthetic results after transection of its humeral insertion. Plast Reconstr Surg (1999) 1.46
Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol (1995) 1.45
Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol (1997) 1.43
Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med (1993) 1.43
Hematopoietic cells transformed in vitro by REVT avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells. Virology (1981) 1.42
Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis. Lancet (1993) 1.42
The impact of two-dimensional pulsed-field gel electrophoresis techniques for the consistent and complete mapping of bacterial genomes: refined physical map of Pseudomonas aeruginosa PAO. Nucleic Acids Res (1991) 1.42
Biogenesis of the yeast lysosome (vacuole): biosynthesis and maturation of proteinase yscB. EMBO J (1988) 1.41
The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein. Virology (1987) 1.41
Robertsonian chromosomal variation and identification of metacentric chromosomes in feral mice. Chromosoma (1972) 1.41
The role of intermolecular interactions: studies on model systems for bacterial biofilms. Int J Biol Macromol (1999) 1.40
Trisomy-18 syndrome caused by translocation or isochromosome formation. A case report with bibliography. J Med Genet (1972) 1.39
Clinical presentation of exclusive cystic fibrosis lung disease. Thorax (1999) 1.39
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet (2000) 1.37
Genome organization of Pseudomonas stutzeri and resulting taxonomic and evolutionary considerations. Int J Syst Bacteriol (1997) 1.37
Endonuclease activity of Escherichia coli DNA helicase I directed against the transfer origin of the F factor. EMBO J (1991) 1.37
The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol (1979) 1.35
Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts. Oncogene (2011) 1.34
Compartmentation of the tryptophan-synthase-proteolyzing system in Saccharomyces cerevisiae. Eur J Biochem (1974) 1.30
Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut (1995) 1.30
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol (2000) 1.29
Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet (1987) 1.29
Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res (2000) 1.29
Monitoring genome evolution ex vivo: reversible chromosomal integration of a 106 kb plasmid at two tRNA(Lys) gene loci in sequential Pseudomonas aeruginosa airway isolates. Microbiology (2000) 1.29
Differential requirement for the mitochondrial Hsp70-Tim44 complex in unfolding and translocation of preproteins. EMBO J (1996) 1.28
In vivo biosynthesis of vacuolar proteinases in proteinase mutants of Saccharomyces cerevisiae. Biochem Biophys Res Commun (1982) 1.28
Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis. FEMS Microbiol Lett (2000) 1.28
Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report. J Cyst Fibros (2011) 1.28
[Leukotactic properties of psoriasis scales]. Hautarzt (1966) 1.27
Influence of calcium ions on the mechanical properties of a model biofilm of mucoid Pseudomonas aeruginosa. Water Sci Technol (2001) 1.27
Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience (1995) 1.27
Chromosome polymorphism in a human newborn population. II. Potentials of polymorphic chromosome variants for characterizing the idiogram of an individual. Cytogenet Cell Genet (1975) 1.26
Molecular analysis of the neutral trehalase gene from Saccharomyces cerevisiae. J Biol Chem (1993) 1.25
Alteration of the cytoskeleton of mammalian cells cultured in vitro by Clostridium botulinum C2 toxin and C3 ADP-ribosyltransferase. Eur J Cell Biol (1991) 1.24
Gradient of genomic diversity in the Pseudomonas aeruginosa chromosome. Mol Microbiol (1995) 1.24
Characterization of the preprotein translocase of the outer mitochondrial membrane by blue native electrophoresis. Biol Chem (1997) 1.23
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros (2011) 1.23
Characterization of mucoid Pseudomonas aeruginosa strains isolated from technical water systems. J Appl Bacteriol (1995) 1.23
[Ornithinemia, additional disorder of amino acid metabolism with brain damage]. Dtsch Med Wochenschr (1968) 1.22
Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J Med Genet (1996) 1.22
Different functions of fetal and adult AChR subtypes for the formation and maintenance of neuromuscular synapses revealed in epsilon-subunit-deficient mice. Eur J Neurosci (2000) 1.22
Myristoylation of budgerigar fledgling disease virus capsid protein VP2. J Virol (1989) 1.22
Analysis of hepatitis C virus core protein interaction domains. J Gen Virol (1997) 1.21
Structural and functional implications of sequence diversity of Pseudomonas aeruginosa genes oriC, ampC and fliC. Electrophoresis (1998) 1.21
Virulence factors of Pseudomonas aeruginosa. Antibiot Chemother (1971) (1987) 1.21
Immunological identification and localization of clathrin and coated vesicles in cultured cells and in tissues. Exp Cell Res (1981) 1.20
Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol (1989) 1.20
The genome of budgerigar fledgling disease virus, an avian polyomavirus. Virology (1988) 1.20
Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy (2002) 1.20